These results indicate that MG may disrupt TJs by activating the TNF-α-NF-κB/MLCK pathway, resulting in increased epithelial permeability, compromised epithelial barrier integrity, and cilia shedding, which promotes the migration of MG within tissues. This evidence concerns the gene MYLK and myasthenia gravis.